Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (181-190 of 336) with videos related to

Pageof 34
Sort By:
Journal of Personalized Medicine|April 28, 2023
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A ReviewDaniela Senior, Rania Ahmed, Eliz Arnavut, et al.
Current Pharmaceutical Biotechnology|April 27, 2023
The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)Elizabeth D Gilley, Abdalla Bowirrat, Ashim Gupta, et al.
Journal of Psychoactive Drugs|August 14, 2012
The addictive brain: all roads lead to dopamineKenneth Blum, Amanda L C Chen, John Giordano, et al.
Brain Sciences|July 27, 2024
Dopamine Dysregulation in Reward and Autism Spectrum DisorderKenneth Blum, Abdalla Bowirrat, Keerthy Sunder, et al.
Clinical Medical Reviews and Case Reports|October 17, 2017
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z<sup>™</sup> Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid DependenceKenneth Blum, Debra Whitney, Lye Fried, et al.
Frontiers in Public Health|May 16, 2025
Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative reviewColin Hanna, Fiona Comstock, Shtakshe Chatrath, et al.
Epigenomes|September 22, 2022
Neurogenetic and Epigenetic Aspects of CannabinoidsCatherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Global Journal of Addiction & Rehabilitation Medicine|October 24, 2017
Critical Analysis of White House Anti-Drug PlanKenneth Blum, Lyle Fried, Margaret A Madigan, et al.
International Journal of Environmental Research and Public Health|June 10, 2022
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?Margaret A Madigan, Ashim Gupta, Abdalla Bowirrat, et al.
Acta Scientific Neurology|January 31, 2022
Neurobiology and Spirituality in Addiction RecoveryA Kenison Roy, Abdalla Bowirrat, David E Smith, et al.
Pageof 34

Showing results (181-190 of 336) with videos related to

Sort By:
Pageof 34
Journal of Personalized Medicine|April 28, 2023
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A ReviewDaniela Senior, Rania Ahmed, Eliz Arnavut, et al.
Current Pharmaceutical Biotechnology|April 27, 2023
The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)Elizabeth D Gilley, Abdalla Bowirrat, Ashim Gupta, et al.
Journal of Psychoactive Drugs|August 14, 2012
The addictive brain: all roads lead to dopamineKenneth Blum, Amanda L C Chen, John Giordano, et al.
Brain Sciences|July 27, 2024
Dopamine Dysregulation in Reward and Autism Spectrum DisorderKenneth Blum, Abdalla Bowirrat, Keerthy Sunder, et al.
Clinical Medical Reviews and Case Reports|October 17, 2017
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z<sup>™</sup> Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid DependenceKenneth Blum, Debra Whitney, Lye Fried, et al.
Frontiers in Public Health|May 16, 2025
Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative reviewColin Hanna, Fiona Comstock, Shtakshe Chatrath, et al.
Epigenomes|September 22, 2022
Neurogenetic and Epigenetic Aspects of CannabinoidsCatherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Global Journal of Addiction & Rehabilitation Medicine|October 24, 2017
Critical Analysis of White House Anti-Drug PlanKenneth Blum, Lyle Fried, Margaret A Madigan, et al.
International Journal of Environmental Research and Public Health|June 10, 2022
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?Margaret A Madigan, Ashim Gupta, Abdalla Bowirrat, et al.
Acta Scientific Neurology|January 31, 2022
Neurobiology and Spirituality in Addiction RecoveryA Kenison Roy, Abdalla Bowirrat, David E Smith, et al.
Pageof 34